Glucocorticosteroids as dengue therapeutics: resolving clinical observations with a primary human macrophage model.
A recent trial [1] investigated the use of a glucocorticosteroid, prednisolone, as a therapy for reduction of severe dengue disease. Many pathogens induce accelerated or excessive inflammation, resulting in detrimental rather than protective effects [2], and dengue virus is a well-characterized exam...
| Principais autores: | , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
Oxford University Press
2012
|